Join our study to help future moms and babies
Are you pregnant and living with psoriasis? You can help advance critical research by joining the Psoriasis Pregnancy Study—a remote, observational study. This means we only collect information; you’ll never be asked to take or change any medication. With over 20 years of experience, MotherToBaby Pregnancy Studies conducts research to provide essential information that helps pregnant women and their healthcare providers make informed decisions about treating chronic health conditions during pregnancy.
Why Participate?
- At-home convenience: All participation is done virtually through phone interviews—no travel or in-person visits required.
- Your experience matters: Contribute to research that tries to understand if psoriasis and its treatments impact pregnancy outcomes.
- Secure and confidential: Your information is protected, and participation fits seamlessly into your daily routine.
Who Can Join?
Pregnant women diagnosed with psoriasis.
How to Sign Up
After you express interest by submitting the form below, our study team will contact you.
What Happens Next?
If you qualify, you will be placed in one of two study groups to help us better understand how psoriasis and its treatments affect pregnancy outcomes and baby health.
1. Psoriasis Group: Study participants who will serve as a comparison to the medication-exposed group.
2. Medication-Exposed Group: Study participants who have taken any of the following psoriasis medications during pregnancy:
- Bimzelx® (bimekizumab-bkzx)
- Ilumya® (tildrakizumab-asmn)
- Sotyktu® (deucravacitinib)
- Tremfya® (guselkumab)